QuanBio is a leading bioengineering company that is revolutionizing the healthcare industry through affordable health and medical diagnostics powered by cutting-edge wearable technology. With a team of innovative thinkers and scientists, QuanBio is developing breakthrough solutions to reshape the vascular screening market. Their team consists of top scientists, leading cardiologists, advisors, partners, and successful entrepreneurs who specialize in medical technology commercialization and product development.

The engineers at QuanBio have extensive experience in industrial design, hardware and circuit board layout design, signal processing, sensor technology, and software solutions. QuanBio's flagship product, the QuanCardio analytics platform, simplifies and accelerates the detection of vascular diseases by analyzing photoplethysmographic signals. This intelligent medical technology helps healthcare professionals deliver quality and timely treatment by making it easier to screen for cardiovascular risk.

Their mission is to bring life-saving, accurate, and affordable technology to enable early detection and monitoring of vascular disease, enabling timely treatment and stopping the progression of the disease. QuanBio's solutions are backed by years of scientific research, clinical data, and verified algorithms, ensuring patient-centered and data-driven care. Please note that QuanBio's cardiovascular solutions are still in development and are not yet approved in the United States